CLASS II ONGOING Device recall · Reported 7 Sep 2022 · FDA Enforcement Report
therascreen Fgfr Rgq Rt-pcr Kit (CE Ivd recalled by Qiagen Sciences
Qiagen Sciences is recalling therascreen Fgfr Rgq Rt-pcr Kit (CE Ivd, not, distributed in Indiana, Minnesota, North Carolina, Texas. The recall was initiated on 20 Jul 2022 and the FDA has classified it as Class II.
Check your package
Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.
Recall details
- Recall number
- Z-1651-2022
- FDA event ID
- 90691
- Recalling firm
- Qiagen Sciences, Germantown, MD
- Classification
- Class II
- Status
- Ongoing
- Recall initiated
- 20 Jul 2022
- FDA classified
- 29 Aug 2022
- Reported
- 7 Sep 2022
- Type
- Voluntary: Firm initiated
- Customers notified by
- Reason category
- Other Reasons
- Device type
- Test Kits & Diagnostics
Timeline
| 20 Jul 2022 | Recall initiated by company | |
| 29 Aug 2022 | Classified by FDA | +40 days |
| 7 Sep 2022 | Published in enforcement report | +9 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Increased occurrence rate of false positive results, lead to a false positive sample result that could subsequently be incorrectly reported from the laboratory. A false positive result could lead to the risk of the patient being exposed to an inappropriate or suboptimal anti-cancer treatment and/or unnecessarily experiencing side effects
Product as listed by the FDA
therascreen FGFR RGQ RT-PCR Kit (CE IVD, not sold in the US) REF 874711
Where it was distributed
IN, NC, MN, TX Foreign: Belgium, China, Germany, Jordan, Italy, Netherlands, Malaysia, Spain, Thailand
Questions about this recall
Why was it recalled?
Increased occurrence rate of false positive results, lead to a false positive sample result that could subsequently be incorrectly reported from the laboratory. A false positive result could lead to the risk of the patient being exposed to an inappropriate or suboptimal anti-cancer treatment and/or unnecessarily experiencing side effects
Which lots are affected?
Lot number: 172017804 Exp Date: 10.11.2022 169046610 Exp. Date: 12.06.2022
Where was it sold?
IN, NC, MN, TX Foreign: Belgium, China, Germany, Jordan, Italy, Netherlands, Malaysia, Spain, Thailand
What should I do if I have it?
Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
Other products in this recall event
2 other products · FDA event 90691This product is part of a recall event; the main page for the event is Fgfr Rgq Rt-pcr Kit (Ruo, not Ivd) recalled by Qiagen Sciences.
| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| CLASS II | Fgfr Rgq Rt-pcr Kit (Ruo, not Ivd) recalled by Qiagen Sciences | Qiagen Sciences | Other | 4 states | |
| CLASS II | therascreen Fgfr Rgq Rt-pcr kit (US Ivd) recalled by Qiagen Sciences | Qiagen Sciences | Other | 4 states |
More recalls from Qiagen Sciences
All 23| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Device | CLASS II | QIAstat-Dx Respiratory Panel Plus Reference Number recalled | Qiagen Sciences | Device Malfunction | 12 states |
| Device | CLASS II | QIAcube Connect MDx - IVD Instrument designed to perform recalled | Qiagen Sciences | Potency & Assay | Nationwide |
| Device | CLASS II | EZ2 Connect MDx-IVD Designed to perform automated isolation recalled | Qiagen Sciences | Temperature Abuse | Nationwide |
| Device | CLASS II | QIAstat-Dx Respiratory Sars-CoV-2 Panel multiplexed nucleic recalled | Qiagen Sciences | Other | Nationwide |
| Device | CLASS II | QIAcube Connect MDx recalled by Qiagen Sciences | Qiagen Sciences | Other | 26 states |
Other Test Kits & Diagnostics recalls
All 2,656| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Device | CLASS II | STA Staclot Protein recalled by Diagnostica Stago | Diagnostica Stago | Potency & Assay | Nationwide |
| Device | CLASS II | DxC 500i Clinical Analyzer Modules using recalled by Beckman Coulter | Beckman Coulter | Packaging Defects | Nationwide |
| Device | CLASS II | DxC 500 AU Clinical Analyzer Modules using recalled by Beckman Coulter | Beckman Coulter | Packaging Defects | Nationwide |
| Device | CLASS II | Syva EMIT 2000 Quinidine Assay recalled | Siemens Healthcare Diagnostics | Potency & Assay | Nationwide |
| Device | CLASS II | Beckman Coulter, Emit 2000 Quinidine Assay recalled | Siemens Healthcare Diagnostics | Potency & Assay | Nationwide |